BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, He Y, Zhang X, Yan X, Huang Y. Clinicopathological analysis of 250 cases of pituitary adenoma under the new WHO classification. Oncol Lett 2020;19:1890-8. [PMID: 32194684 DOI: 10.3892/ol.2020.11263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hinojosa-Amaya JM, Lam-Chung CE, Cuevas-Ramos D. Recent Understanding and Future Directions of Recurrent Corticotroph Tumors. Front Endocrinol (Lausanne) 2021;12:657382. [PMID: 33986726 DOI: 10.3389/fendo.2021.657382] [Reference Citation Analysis]
2 Hong SW, Kim SH, Lim SH, Lee EJ, Kim SH, Ku CR, Kim EH. Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience. Front Oncol 2021;11:739290. [PMID: 34589436 DOI: 10.3389/fonc.2021.739290] [Reference Citation Analysis]
3 Jiang S, Zhu J, Feng M, Yao Y, Deng K, Xing B, Lian W, Wang R, Bao X. Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary 2021;24:564-73. [PMID: 33651318 DOI: 10.1007/s11102-021-01133-8] [Reference Citation Analysis]